Cochlear Limited reported flat sales revenue of $2,343.4 million for the financial year ended 30 June 2026, compared with $2,347.6 million in the prior year. Statutory net profit collapsed 62% to $147.3 million from $388.9 million, a dramatic decline that appears disconnected from revenue stability. The gap between flat sales and sharply lower profits signals substantial margin compression and significant one-off charges that warrant closer examination.
The underlying profit reconciliation reveals two major drivers of the earnings collapse. Cloud computing expenses surged to $94.3 million in FY26 from minimal levels in the prior year, representing a strategic investment in digital infrastructure transformation. The company also recorded $121.4 million in non-cash fair value losses and impairments on its investment portfolio. Management strips out cloud costs from underlying earnings to highlight operational performance, presenting an 18% decline in underlying net profit to $322.4 million as more representative of sustainable earning power going forward.
Basic earnings per share fell 62% to 225.2 cents on a statutory basis, while underlying earnings per share declined 18% to 492.9 cents. The divergence between statutory and underlying metrics underscores management’s message that FY26 included material one-time headwinds, particularly the elevated cloud investment that is positioned as a non-recurring strategic pivot. Net tangible assets per share fell 13% to 1,922.5 cents, reflecting both the profit decline and capital consumed by infrastructure investment.
Management’s dividend decision reinforces a more cautious outlook. The full-year dividend was cut 20% to $3.45 per share, with a final dividend of $1.30 payable in October. This represents a material reduction from $4.30 in the prior year and signals that management believes near-term earnings visibility warrants more conservative capital allocation.
The underlying earnings decline, while less severe than headline figures suggest, still represents a concerning trend when viewed alongside revenue stagnation. If Cochlear were growing sales and improving operational leverage, underlying profits should be rising despite cloud investment. Instead, flat revenues coupled with falling operational profits point to either market headwinds in core hearing healthcare markets or deteriorating competitive positioning. The $121 million in investment losses compounds this concern and raises questions about portfolio management.
The critical question for investors is whether Cochlear’s cloud infrastructure investment delivers the expected revenue uplift and efficiency gains to justify near-term margin pressure. The company faces an earnings recovery hurdle, needing to demonstrate that FY26 marked a trough year with improving profitability ahead. Upcoming quarterly sales reports will be essential to monitor for signs of revenue acceleration and stabilization in core markets.
This announcement is flagged as price sensitive and constitutes material information under ASX listing rules.
View the full ASX announcement (PDF)
About Cochlear Limited (ASX: COH)
Cochlear Limited is the world’s leading manufacturer of cochlear implant devices and other implantable hearing solutions for individuals with severe to profound hearing loss. The company develops and manufactures cochlear implant systems, bone conduction devices, sound processors, and related accessories for children and adults worldwide. Headquartered in Sydney, Australia, Cochlear operates across developed markets in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific region.
If you would like to discuss this announcement or how it might affect your portfolio, request a callback or call us on 1300 889 603.
